Cookie Policy         The Babraham Research Campus is also home to The Babraham Institute


  Babraham Bioscience Technologies
        Babraham Research Campus - Cambridge - UK
 

News
  2016
  2015
  2014
  2013
  2012
  2011
  2010
  2009
  2008
  2007

Video Library

Events

Press Releases and Media Reports 2008

 

 

11th December 2008
Cancer Companies at Babraham's Bioincuabtor win Major Awards for Medical Innovation

 

10th December 2008
Senexis to collaborate with Alzhyme on Alzheimer's diagnostics

 

4th December 2008
Minister for the East of England visits the Babraham Research Campus and new Technology Development Laboratory

 

10th September 2008
Pronostics to supply Hannover Medical School with next generation diagnostics for autoimmune disease

 

5th September 2008
ImmBio-Led Consortium Releases Promising Data for Meningitis B Vaccine

 

25th July 2008
Pronostics set for European expansion with digital multiplexing solution

 

18th June 2008
MedCell and NovaThera Merge

 

9th May 2008
Babraham's 5th Biotechnology Investment Forum draws French Biotech Companies

 

6th May 2008
Isogenica completes acquisition of the principal assets of Karyon CTT

 

4th April 2008
Biovitrum's unique neuropathic pain compound is very safe and shows positive effect

 

1st April 2008
NOVAPOD™ - Anglo-China Manufacturing Agreement Signed Following Market Success

 

13th March 2008
NovaThera signs Licensing Agreement for 3D Stem Differentiation and Production

 

12th March 2008
Antibody Engineering Company F-Star Opens Second Research Site in Cambridge, UK

 

12th March 2008
Pronostics signs distribution agreement with MEDIPAN GmbH to sell its lead products in Europe's largest diagnostics market

 

19th February 2008
Population Genetics Technologies Raises £3.8M in Series A Funding; Appoints Mel N. Kronick Chief Executive Officer

 

15th February 2008
Stem Cell Sciences Implements Strategic Reorganisation

 

14th February 2008
Senexis and O2H (Oxygen Healthcare) announce medicinal chemistry collaboration

 

6th February 2008
Probe Scientific takes a major step forward with development and distribution plans

 

5th February 2008
Senexis Joins International Research Consortium: European Union grants £3 million to the consortium for research into the investigation of memory loss in Alzheimer's disease

 

30th January 2008
Stem Cell Sciences Enters Agreement with Myelin Repair Foundation to Develop Sustainable Cell Sources for CNS Drug Discovery

 

17th January 2008
Senexis Raises £3.7M from the Wellcome Trust & BTG to Further Develop its Small Molecule Alzheimer's Compounds

 

 

 

Babraham Bioscience Technologies Ltd - Cambridge - United Kingdom